Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911141 · ClinicalTrials.gov registry record · NA
Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease
A NA study of Atherosclerotic Cardiovascular Disease, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,062
- Enrollment target
- 1
- Study location
NCT03911141: Completed NA study of Atherosclerotic Cardiovascular Disease, sponsored by University of Pennsylvania.
NCT03911141 is a NA study of Atherosclerotic Cardiovascular Disease that has completed, run by University of Pennsylvania. The registered enrollment target is 1,062 participants, below the 7,517-participant average among 21 other Atherosclerotic Cardiovascular Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03911141, a NA study of Atherosclerotic Cardiovascular Disease, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,062 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to use a randomized, controlled trial to test the effectiveness of using gamification, financial incentives, or both to increase physical activity among patients with elevated risk for atherosclerotic cardiovascular disease (ASCVD). ASCVD is the leading cause of morbidity and mortality in the United States. Regular physical activity has been shown to reduce the risk of ASCVD, but less than 50% of US adults achieve enough physical activity to obtain these benefits.
Primary Outcome
Change in mean daily steps counts from baseline to the 12-month intervention period, excluding the 8-week ramp-up phase. This will be measured using the Fitbit Charge wearable device.
Conditions Studied
Interventions
- BEHAVIORAL Gamification
- BEHAVIORAL Financial
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,062 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2024-01-27 |
| Phase | NA |
What the finished NCT03911141 record still lists
NCT03911141 is an interventional study that assigns participants to a tested intervention. Its 1,062 participants enrollment target places it among the larger protocols in the corpus, below the 7,517-participant average among 21 other Atherosclerotic Cardiovascular Disease trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Atherosclerotic Cardiovascular Disease appearing as the primary indexed condition, and to 2 interventions - of which Gamification is the first listed.
NCT03911141 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03911141 about?
NCT03911141 is a clinical study titled "Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease". The objective of this study is to use a randomized, controlled trial to test the effectiveness of using gamification, financial incentives, or both to increase physical activity among patients with elevated risk for atherosclerotic cardiovascular disease (ASCVD). ASCVD is the leading cause of morbid...
What is the current status of trial NCT03911141?
This trial is currently completed. It is a NA study. The enrollment target is 1,062 participants. The study started on 2019-04-12. Estimated completion is 2024-01-27.
What conditions does trial NCT03911141 study?
This clinical trial studies the following conditions: Atherosclerotic Cardiovascular Disease.
What interventions are being tested in trial NCT03911141?
The interventions under investigation include: Gamification (BEHAVIORAL), Financial (BEHAVIORAL).
Who is sponsoring clinical trial NCT03911141?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03911141 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerotic Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03911141's enrollment target sits among peer trials
1,062 10th of 21 higher than 12 of 21 other Atherosclerotic Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atherosclerotic Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
RECRUITING · NA
-
Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
RECRUITING · NA
-
The Young Heart Study
ACTIVE NOT RECRUITING · NA
-
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
COMPLETED · NA
-
Recipe for Heart Health
COMPLETED · NA
-
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI